Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_assertion type Assertion NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_head.
- NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_assertion description "[This paper will conclude with a timely examination of the current status of TM's growing therapeutic appeal, from novel strategies to improve the clinical efficacy of recombinant TM analogs for resolution of vascular disorders such as disseminated intravascular coagulation (DIC), to an examination of the complex pleiotropic relationship between statin treatment and TM expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_provenance.
- NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_assertion evidence source_evidence_literature NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_provenance.
- NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_assertion SIO_000772 23604713 NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_provenance.
- NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_assertion wasDerivedFrom befree-20150227 NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_provenance.
- NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_assertion wasGeneratedBy ECO_0000203 NP735694.RAVKqgnR96OCU9os7I2TxjyIfDvrpJkLoWFta1A4xI0o8130_provenance.